Chemo Espana SA-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Chemo Espana SA-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH177740D
  • |
  • Pages: 37
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Chemo Espana SA (Chemo Group) is a pharmaceutical company, which conducts research, development, manufacture, sales and marketing of active pharmaceutical ingredients (APIs), finished dosage forms and branded pharmaceuticals. Its product portfolio includes steroids, hormones and antibiotics in different formulations such as tablets, capsules, injectables and suspensions. The company's target therapy areas include cardiovascular, gastroenterology, anti-infective, central nervous system, respiratory, women's healthcare, endocrinology, dermatology and urology. Chemo Group's OTC division develops food supplements in the form of soft gel capsules, hard capsules, tablets, pellets, sachets to cosmetics covering metabolic syndrome, digestive disorders, women and men healthcare, weigh control or quality of life. It has presence in Europe, South America, Asia and North America. Chemo Group is headquartered in Madrid, Spain.

Chemo Espana SA-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Chemo Espana SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Chemo Espana SA, Medical Devices Deals, 2011 to YTD 2017 11

Chemo Espana SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12

Chemo Espana SA, Pharmaceuticals & Healthcare, Deal Details 14

Asset Purchase 14

Exeltis Acquires Juste Farma Division from Juste labs 14

Ordain Health Care Acquires Fertica Business from Alkem Labs for USD4 Million 14

Partnerships 16

mAbxience Partners with World Health Organization and Utrecht Centre of Excellence for Affordable Biotherapeutics for Public Health 16

EPIRUS Biopharma Enters into Distribution Agreement with mAbxience 16

Natco Pharma Enters Into Agreement With MAbxience For Monoclonal Antibodies 17

GH Genhelix Enters Into Co-Promotion Agreement With Toyota Tsusho 18

Licensing Agreements 19

Exeltis Enters into Licensing Agreement with Neurim Pharma 19

Chemo Enters into Licensing Agreement with IntelGenx 20

Stada Arzneimittel to Enter into Licensing Agreement with mAbxience 20

Libbs Farma Enters Into Licensing Agreement With mAbxience For Biosimilar Monoclonal Antibodies 21

Acquisition 22

Exeltis Acquires Embil Pharma 22

mAbxience Acquires GH Genhelix for USD13.5 Million 23

Exeltis Acquires Althea Pharma 23

Everett Labs Acquires Quinnova Pharma From AmDerma Pharma 24

Chemo Espana Acquires 75% Stake In Nufarindo 25

Chemo Group Completes Acquisition Of 60% Stake In Ordain Health Care 26

Chemo Group Acquires 50% Stake In Laboratorios de Productos Eticos 27

Chemo Group Acquires Remaining 50% Joint Venture Stake In Laboratorios Elea Mexico 28

Chemo Group Acquires Remaining 50% Joint Venture Stake In Servicios Elche 28

Chemo Group Acquires Remaining 50% Stake In Sinensix Pharma (Thailand) 29

Chemo Espana SA-Key Competitors 31

Key Employees 32

Locations And Subsidiaries 33

Head Office 33

Other Locations & Subsidiaries 33

Recent Developments 36

Legal and Regulatory 36

Jan 07, 2016: Chemo renews the ISO 14001 environmental certificate of its Laboratorios Liconsa pharmaceutical plant in Azuqueca de Henares 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37

List of Figures

Chemo Espana SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Chemo Espana SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Chemo Espana SA, Medical Devices Deals, 2011 to YTD 2017 11

List of Tables

Chemo Espana SA, Pharmaceuticals & Healthcare, Key Facts 1

Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Chemo Espana SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Chemo Espana SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Chemo Espana SA, Deals By Therapy Area, 2011 to YTD 2017 9

Chemo Espana SA, Medical Devices Deals, 2011 to YTD 2017 11

Chemo Espana SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12

Exeltis Acquires Juste Farma Division from Juste labs 14

Ordain Health Care Acquires Fertica Business from Alkem Labs for USD4 Million 14

mAbxience Partners with World Health Organization and Utrecht Centre of Excellence for Affordable Biotherapeutics for Public Health 16

EPIRUS Biopharma Enters into Distribution Agreement with mAbxience 16

Natco Pharma Enters Into Agreement With MAbxience For Monoclonal Antibodies 17

GH Genhelix Enters Into Co-Promotion Agreement With Toyota Tsusho 18

Exeltis Enters into Licensing Agreement with Neurim Pharma 19

Chemo Enters into Licensing Agreement with IntelGenx 20

Stada Arzneimittel to Enter into Licensing Agreement with mAbxience 20

Libbs Farma Enters Into Licensing Agreement With mAbxience For Biosimilar Monoclonal Antibodies 21

Exeltis Acquires Embil Pharma 22

mAbxience Acquires GH Genhelix for USD13.5 Million 23

Exeltis Acquires Althea Pharma 23

Everett Labs Acquires Quinnova Pharma From AmDerma Pharma 24

Chemo Espana Acquires 75% Stake In Nufarindo 25

Chemo Group Completes Acquisition Of 60% Stake In Ordain Health Care 26

Chemo Group Acquires 50% Stake In Laboratorios de Productos Eticos 27

Chemo Group Acquires Remaining 50% Joint Venture Stake In Laboratorios Elea Mexico 28

Chemo Group Acquires Remaining 50% Joint Venture Stake In Servicios Elche 28

Chemo Group Acquires Remaining 50% Stake In Sinensix Pharma (Thailand) 29

Chemo Espana SA, Key Competitors 31

Chemo Espana SA, Key Employees 32

Chemo Espana SA, Other Locations 33

Chemo Espana SA, Subsidiaries 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Chemo Espana SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16190
Site License
USD 500 INR 32380
Corporate User License
USD 750 INR 48570

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com